Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 0.58%85.682.1%$236.46m
SAVACassava Sciences, Inc. 0.88%11.510.0%$215.42m
HZNPHorizon Therapeutics Plc -0.61%77.685.8%$168.24m
JAZZJazz Pharmaceuticals Plc 2.04%142.592.4%$167.73m
MRNSMarinus Pharmaceuticals, Inc. 10.59%12.857.8%$139.82m
CORTCorcept Therapeutics, Inc. -0.83%17.415.5%$123.16m
VRXValeant Pharmaceuticals International, Inc. 4.50%15.5514.1%$91.50m
BHCBausch Health Cos., Inc. 4.50%15.550.0%$64.17m
MYOKMyoKardia, Inc. 1.64%136.331.8%$63.39m
AMRNAmarin Corp. Plc 4.21%4.211.5%$60.54m
ARGXargenx SE 0.89%262.520.0%$53.94m
SAGESAGE Therapeutics, Inc. 2.43%61.128.6%$44.03m
GWPHGW Pharmaceuticals Plc -0.48%97.356.2%$39.09m
AXSMAxsome Therapeutics, Inc. -1.43%71.251.9%$37.48m
PRGOPerrigo Co. Plc 0.53%45.916.8%$37.00m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.